Epoxyeicosatrienoic Acid Analog EET-A Blunts Development of Lupus Nephritis in Mice
Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disorder that causes life threatening renal disease and current therapies are limited with serious side-effects. CYP epoxygenase metabolites of arachidonic acid epoxyeicosatrienoic acids (EETs) demonstrate strong anti-inflammato...
Main Authors: | Md. Abdul Hye Khan, Anna Stavniichuk, Mohammad Abdul Sattar, John R. Falck, John D. Imig |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00512/full |
Similar Items
-
Early Renal Vasodilator and Hypotensive Action of Epoxyeicosatrienoic Acid Analog (EET-A) and 20-HETE Receptor Blocker (AAA) in Spontaneously Hypertensive Rats
by: Agnieszka Walkowska, et al.
Published: (2021-01-01) -
Epoxyeicosatrienoic Acid Analog Decreases Renal Fibrosis by Reducing Epithelial-to-Mesenchymal Transition
by: Melissa Skibba, et al.
Published: (2017-06-01) -
Urinary angiostatin, CXCL4 and VCAM-1 as biomarkers of lupus nephritis
by: Chi Chiu Mok, et al.
Published: (2018-01-01) -
The relation between intra-renal gene expression and histological pattern of lupus nephritis.
Published: (2011) -
USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)